DZ Bank’s Boston Scientific BSX Stock Holding History

DZ Bank’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$58.3M	Buy	+937,000	New	+$75M	0.05%	171

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DZ Bank's BSX Position: Q1 2026 in Review

DZ Bank reduced its Boston Scientific (BSX) stake by 29% in Q1 2026, selling an estimated $425M and leaving 13,229,644 shares worth $830M. The position accounts for 0.74% of the portfolio, ranked #38.

DZ Bank first reported a position in BSX in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.99B in Q4 2024. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

DZ Bank held 13,229,644 shares of Boston Scientific worth $830M as of Q1 2026.
DZ Bank sold 5,311,049 Boston Scientific shares in Q1 2026, an estimated $425M.
Boston Scientific made up 0.74% of DZ Bank's portfolio in Q1 2026, its #38 holding.
DZ Bank first reported a position in Boston Scientific in Q4 2016 and has held it in 38 quarters since.
DZ Bank's Boston Scientific position peaked at $1.99B in Q4 2024.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on DZ Bank's 13F filing for Q1 2026, filed 15 May 2026.